Skip to main content
logo
Valerio Therapeutics Société anonyme (EPA:ALVIO)
France flag France · Delayed Price · Currency is EUR
0.1462
-0.0058 (-3.82%)
Apr 24, 2026, 4:22 PM CET

EPA:ALVIO Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-13.18-23.93-20.34-19.56-5.941.09
Depreciation & Amortization
11.5812.980.480.530.60.53
Other Amortization
-----0.06
Loss (Gain) From Sale of Assets
-0.86-0.79---0.06
Asset Writedown & Restructuring Costs
---0.21-0.18-0.29
Stock-Based Compensation
0.270.390.510.720.220.08
Other Operating Activities
3.072.982.631.780.86-7.09
Change in Other Net Operating Assets
-10.1-4.09-0.676.88-4.140.89
Operating Cash Flow
-9.23-12.46-17.39-9.44-8.57-4.68
Capital Expenditures
-0.39-0.32-0.18-0.49-0.14-0.12
Sale of Property, Plant & Equipment
0.14----6.12
Divestitures
-1.08-1.08---0.01
Investment in Securities
0.010.010.010.080.070
Other Investing Activities
00-0-0--
Investing Cash Flow
-1.32-1.39-0.18-0.41-0.076.02
Long-Term Debt Issued
----3.11-
Total Debt Issued
0.39---3.11-
Long-Term Debt Repaid
--1.36-1.23-1.51-0.49-3.09
Net Debt Issued (Repaid)
-0.56-1.36-1.23-1.512.62-3.09
Issuance of Common Stock
0.070.0212.147.979.3510.58
Repurchase of Common Stock
---0.13---
Other Financing Activities
5.545.54-0.0300-0
Financing Cash Flow
5.054.2110.766.4611.987.48
Foreign Exchange Rate Adjustments
0.04-0.120.240.090.03-0
Miscellaneous Cash Flow Adjustments
4.094.09-1.210--
Net Cash Flow
-1.37-5.66-7.77-3.33.368.82
Free Cash Flow
-9.62-12.78-17.57-9.93-8.71-4.8
Free Cash Flow Margin
-525.41%-712.72%-976.33%-688.22%-214.45%-270.10%
Free Cash Flow Per Share
-0.06-0.08-0.13-0.09-0.10-0.06
Levered Free Cash Flow
5.475.57-9.83-2.92-7.36-8.97
Unlevered Free Cash Flow
5.735.77-9.7-1.55-6.83-8.37
Change in Working Capital
-10.1-4.09-0.676.88-4.140.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.